(Q36966036)

17 August 2017

1 reference

title

The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiency (English)

1 reference

17 August 2017

0 references

Pedro E Cruz

1

1 reference

17 August 2017

Christian Mueller

series ordinal

2

1 reference

17 August 2017

Terence R Flotte

series ordinal

3

1 reference

17 August 2017

publication date

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

9

1 reference

17 August 2017

page(s)

1191-1198

1 reference

Complete sequence of the cDNA for human .alpha.1-antitrypsin and the gene for the S variant

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Transfection of nasal mucosa with a normal alpha1-antitrypsin gene in alpha1-antitrypsin-deficient subjects: comparison with protein therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Expression of the alpha 1-proteinase inhibitor gene in human monocytes and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Epstein-Barr virus/human vector provides high-level, long-term expression of alpha1-antitrypsin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Pig liver gene therapy by noninvasive interventionist catheterism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Gene therapy for human alpha1-antitrypsin deficiency in an animal model using SV40-derived vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Recombinant adeno-associated virus as delivery vector for gene therapy--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Recombinant adeno-associated virus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Enhancing rAAV vector expression in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Adeno-associated virus vectors in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Adeno-associated virus-based gene therapy for inherited disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Recent developments in recombinant AAV-mediated gene therapy for lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Biochemical efficacy and safety of a new pooled human plasma alpha(1)-antitrypsin, Respitin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Cost-effectiveness analysis of augmentation therapy for severe alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Delayed expression of adeno-associated virus vector DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Tolerance for mutations and chemical modifications in a siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Designing siRNA that distinguish between genes that differ by a single nucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Engineering artificially split inteins for applications in protein chemistry: biochemical characterization of the split Ssp DnaB intein and comparison to the split Sce VMA intein

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

Development of a tandem protein trans-splicing system based on native and engineered split inteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

In vivo trans-splicing of 5' and 3' segments of pre-mRNA directed by corresponding DNA sequences delivered by gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1191

10.2217/14622416.8.9.1191

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference